Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of 7-day montelukast on AMP-induced bronchoprovocation in mild to moderate allergic asthma
2006-000334-12Phase 4Completed
- Sponsor
- Almirall
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of montelukast in asthma (2 arms), sponsored by Almirall. Primary endpoints: PC20 AMP and Recovery time following AMP challenge. Started Aug 2006; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-000334-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000334-12.